Inspire Investing LLC Sells 912 Shares of Encompass Health Co. (NYSE:EHC)

Inspire Investing LLC reduced its stake in Encompass Health Co. (NYSE:EHC) by 2.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 33,558 shares of the company’s stock after selling 912 shares during the period. Inspire Investing LLC’s holdings in Encompass Health were worth $2,879,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of EHC. Vanguard Group Inc. boosted its holdings in Encompass Health by 1.7% during the first quarter. Vanguard Group Inc. now owns 10,166,147 shares of the company’s stock worth $839,520,000 after purchasing an additional 169,113 shares during the last quarter. Wellington Management Group LLP increased its holdings in Encompass Health by 5.8% during the 4th quarter. Wellington Management Group LLP now owns 8,215,770 shares of the company’s stock worth $548,156,000 after acquiring an additional 449,230 shares during the period. TD Asset Management Inc increased its holdings in Encompass Health by 16.0% during the 1st quarter. TD Asset Management Inc now owns 2,283,674 shares of the company’s stock worth $188,586,000 after acquiring an additional 314,488 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of Encompass Health by 1.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,819,345 shares of the company’s stock worth $156,083,000 after buying an additional 22,311 shares during the last quarter. Finally, Epoch Investment Partners Inc. increased its holdings in shares of Encompass Health by 14.2% in the 1st quarter. Epoch Investment Partners Inc. now owns 1,598,042 shares of the company’s stock worth $131,966,000 after buying an additional 198,701 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on EHC shares. UBS Group upped their price objective on shares of Encompass Health from $96.00 to $100.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Leerink Partnrs upgraded shares of Encompass Health to a “strong-buy” rating in a research note on Wednesday, July 10th. Truist Financial raised their price objective on shares of Encompass Health from $100.00 to $104.00 and gave the company a “buy” rating in a research note on Thursday, August 15th. Leerink Partners started coverage on shares of Encompass Health in a research note on Wednesday, July 10th. They set an “outperform” rating and a $100.00 price objective for the company. Finally, Stephens reaffirmed an “overweight” rating and set a $105.00 price target on shares of Encompass Health in a report on Tuesday, August 6th. Nine research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $100.38.

Encompass Health Stock Performance

Shares of Encompass Health stock opened at $92.44 on Thursday. Encompass Health Co. has a 52 week low of $57.55 and a 52 week high of $94.59. The business’s fifty day simple moving average is $89.80 and its 200-day simple moving average is $85.08. The firm has a market cap of $9.31 billion, a PE ratio of 24.98, a price-to-earnings-growth ratio of 1.39 and a beta of 0.88. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.08.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Monday, August 5th. The company reported $1.11 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.10. Encompass Health had a return on equity of 17.83% and a net margin of 7.88%. The company had revenue of $1.30 billion for the quarter, compared to the consensus estimate of $1.30 billion. During the same quarter in the prior year, the business earned $0.95 EPS. Encompass Health’s revenue was up 9.6% on a year-over-year basis. Equities analysts forecast that Encompass Health Co. will post 4.18 earnings per share for the current year.

Encompass Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Tuesday, October 1st will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.74%. This is a boost from Encompass Health’s previous quarterly dividend of $0.15. The ex-dividend date is Tuesday, October 1st. Encompass Health’s dividend payout ratio (DPR) is presently 18.38%.

Insiders Place Their Bets

In other news, CFO Douglas E. Coltharp sold 12,260 shares of the firm’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total value of $1,058,528.40. Following the completion of the sale, the chief financial officer now directly owns 136,227 shares of the company’s stock, valued at approximately $11,761,839.18. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 2.10% of the stock is owned by insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.